Cystic EchinococcosisNCT07333612
IM Bands in Inactive Hepatic CE
An observational study of Cystic Echinococcosis, run by Fondazione IRCCS Policlinico San Matteo di Pavia at 1 site in Italy.
Trial summary
Comparison of immunoblotting bands pattern in patients with treated versus untreated echinococcal cysts of the liver Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Cystic Echinococcosis
- How many people
- 100 participants
- Where
- 1 siteItaly
- Study dates
- 23 Sep 2025to 1 Sep 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: patients affected by cystic echinococcosis of the liver.
Who may be able to join
- Only Hepatic echinococcal cysts
- Age > 18 years
- At leat 2 clinical evaluation
Who cannot join
- different location of echinococcal cysts
- Age < 18 years --less then 2 clinical evalutation
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Italy1 site, 1 recruiting
- Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Pavia, PV, 27100
Raffaella Lissandrin, 3355853501, R.Lissandrin@smatteo.pv.it
About this study
Official title: Comparison of Immunoblotting Bands Pattern in Patients With Treated Versus Untreated Inactive Echinococcal Cysts of the Liver
Comparison of immunoblotting bands pattern in patients with treated versus untreated echinococcal cysts of the liver
- Conditions
- Cystic Echinococcosis
- Medical subject headings
- Echinococcosis
What is being measured
The primary outcome is the main question the study is designed to answer.
Percentage of patients with spontaneously inactivated hepatic CE cysts with positive WB and RT t differente times from diagnosis.
from 0 to 100%
Measured: from September 2024 to September 2026
Secondary outcomes (2)
Percentage of cysts that remaine inactive after treatment or reactivate
from 0 to 100%
Measured: from september 2024 to September 2026
Percentage of patients with inactivated cysts after treatment with positive WB results at different time point from the first observation of an inactive stage.
from 0 to 100%
Measured: from September 2024 to September 2026
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Jan 2026
- Study start23 Sep 2025
- Primary completion1 May 2026 (estimated)
- Study completion1 Sep 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cystic EchinococcosisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Raffaella Lissandrin, Fondazione IRCCS Policlinico San Matteo di Pavia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07333612
- Sponsor's protocol ID
- 08075323
- Status last verified
- Dec 2025
- First submitted
- 30 Dec 2025
- Last updated
- 12 Jan 2026
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 12 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of Immunoblotting Bands Pattern in Patients With Treated Versus Untreated Inactive Echinococcal Cysts of the Liver
- ClinicalTrials.gov ID
- NCT07333612
- Acronym / sponsor ID
- 08075323
- Conditions
- Cystic Echinococcosis
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Fondazione IRCCS Policlinico San Matteo di PaviaUniversity, hospital or other
- Study start
- 23 Sep 2025 (actual)
- Primary completion
- 1 May 2026 (estimated)
- Study completion
- 1 Sep 2026 (estimated)
- First posted
- 12 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Comparison of immunoblotting bands pattern in patients with treated versus untreated echinococcal cysts of the liver
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- patients affected by cystic echinococcosis of the liver.
Key inclusion criteria (3 listed)
- Only Hepatic echinococcal cysts
- Age > 18 years
- At leat 2 clinical evaluation
Key exclusion criteria (2 listed)
- different location of echinococcal cysts
- Age < 18 years --less then 2 clinical evalutation
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Percentage of patients with spontaneously inactivated hepatic CE cysts with positive WB and RT t differente times from diagnosis.
Time frame: from September 2024 to September 2026
from 0 to 100%
2 secondary outcomes
Percentage of cysts that remaine inactive after treatment or reactivate
Time frame: from september 2024 to September 2026
Percentage of patients with inactivated cysts after treatment with positive WB results at different time point from the first observation of an inactive stage.
Time frame: from September 2024 to September 2026
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Jan 2026.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cystic Echinococcosis, run by Fondazione IRCCS Policlinico San Matteo di Pavia at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 12 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Percentage of patients with spontaneously inactivated hepatic CE cysts with positive WB and RT t differente times from diagnosis. (time frame: from September 2024 to September 2026). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jan 2026; AzTrials last refreshed its copy on 26 Oct 2026.